Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells.

Abstract

These data indicate that Pgp overexpression is functional in refractory myeloma and that clinical modulation of MDR by CSA is mediated through an inhibition of Pgp-associated drug efflux. Pgp-expressing PC can be eliminated by clinical treatment with VAD/CSA.